Loading

Journal of Veterinary Medicine and Research

Effects of the Aflatoxin B1 Given in Ovo on the Histomorphological Changes of Developing Cerebellar Cortex and the AgNOR Activity of the Purkinje cell Nuclei of Chickens

Research Article | Open Access

  • 1. Department of Histology and Embryology, University of Selcuk, Turkey
+ Show More - Show Less
Corresponding Authors
Tugba Ozayd?n, Department of Histology and Embryology, Faculty of Veterinary Medicine, University of Selcuk, Konya, Turkey
Abstract

In this study, the effects of in ovo administrated aflatoxin B1 (AFB1) on the histomorphological changes of developing cerebellar cortex and the AgNOR activity of the Purkinje cell nuclei of chickens in the post-hatching period were investigated. For this purpose, 730 laying hen eggs were divided into 7 groups [3 control groups (nottreated, drilled-sealed and 30% ethanol (solvent)-injected groups) and 4 assay groups in which eggs were injected with increasing AFB1 doses (2.5, 7.5, 12.5 and 17.5 ng/ egg)] then conventionally incubated. Tissue samples were taken from six animals of each control and experimental groups on the hatching day and 10th, 20th and 28th days after hatching. The samples, which were fixed in 4% neutral-buffered formalin, were dehydrated, cleared, and embedded in paraffin. The sections taken from the paraffin blocks were stained with haematoxylin-eosin and AgNOR staining methods. Quantitative computer assisted morphometric study was done on the cortical layer of the cerebellum. Histomorphometric examination revealed that there were no significant differences among the groups in the thicknesses of molecular and granular cell layer at summit and in the fissure of folium of the cerebellar cortex and AgNOR parameters of Purkinje cell nuclei. In conclusion the administration of a low concentration of AFB1 in ovo at the beginning of early embryonic development may not profoundly affect the development of the cerebellar cortex or the damage to the cerebellum, if occurring, might get repaired during subsequent stages of development.

Keywords


• AFB1
• Cerebellar cortex
• AgNOR
• chicken

Citation

Ozayd?n T, Sur E (2015) Effects of the Aflatoxin B1 Given in Ovo on the Histomorphological Changes of Developing Cerebellar Cortex and the AgNOR Activity of the Purkinje cell Nuclei of Chickens. J Vet Med Res 2(3): 1024

ABBREVIATIONS

AF: Aflatoxin; AFB1 : Aflatoxin B1 ; CNS: Central Nervous System; NORs: Nucleolus Organizer Regions

INTRODUCTION

Aflatoxins (AFs) are extremely toxic metabolites of Aspergillusflavusand Aspergillusparasiticus [1,2]. Although AFs consist of a group of approximately 18 related fungal metabolites, only AFB1 , AFB2 , AFG1 , and AFG2 have been detected in food and foodstuffs [3]. Among these AFs, AFB1 is one of the most important food borne mycotoxins due to its biological effects and widespread toxicity [4,5]. AFB1 induces acute toxicity in most animal species and is known as being one of the most potent genotoxic agents and hepatocarcinogenes [6]. Teratogenic effects of AFB1 have also been reported in some species [5,7-12].

AFs causeeconomic losses to poultry production because aflatoxicosis results in listlessness, anorexia, poor food utilization, decreased body weight gain, decreased egg production, increased susceptibility to microbial and unspecified diseases and increased mortality [13]. In addition the dietary AF and their metabolites infiltrate and accumulate most of the soft tissues and fat depots of chicken, and they can also be transferred to eggs [14]. In poultry food and food-stuffs, this contamination and residue may have little significance for human health, but it can be a serious veterinary problem in the poultry industry because of the residues in fertilized eggs [15].

The central nervous system (CNS) is well protected by the blood-brain barrier and neurotoxicity often involves peripheral nervous system effects in adults. However developing CNS at prenatal and early post natal periods is more susceptible to several factors induced neurotoxicity than in adults due to the lack of a protective barrier. A large number of processes occur at the different stages of development such as cell proliferation, migration, differentiation and apoptosis. Chemicals can freely enter the developing CNS and may exert deleterious effects by interfering with these processes [16].The main mechanisms of mycotoxin toxicity include stimulation of lipid peroxidation, apoptosis and inhibition of DNA, RNA and protein synthesis [17].There is a delicate balance among cell proliferation, cell differentiation and apoptosis in the developing embryo; impairment in these mechanisms due to mycotoxins might have been responsible for the anomalies observed [18]. Although the microscopic examination of serial sections of visceral organs may detect cellular alterations due to AFB1 , the histological evaluation associated with the effects of AFB1 on the developing CNS are still lacking.

The cerebellum is one of the best studied regions of the CNS because of its well-defined cytoarchitecture and pathways of cerebellar cell migration during neurogenesis [19].The key cellular elements of the cerebellar cortex include granule cells and the Purkinje cells. Both cell types have properties that make them attractive to experimental investigations and thus these cells are widely used in many studies of cerebellar development [20].

Nucleolus organizer regions (NORs) are loops of DNA that contain genes responsible for the transcription of ribosomal RNA [21]. Since proteins of these regions can be identified as small black dots in the nucleus using silver staining techniques, they are named AgNORs [22]. An increase in the number and size of AgNORs in interphase nuclei highly correlates with cellular hyperactivity and might give a valuable indicate of the proliferation rate, differentiation process and secretory activity of a given cell. In addition these changes appear to be of value in aiding the diagnosis in malignant transformation [23-26].

Neurotoxicity is usually defined as a structural changes or a functionally adverse response of the nervous system, resulting from exposure to a chemical, biological or physical agent [16]. The present study was carried out to evaluate the possible neurotoxic effects of in ovo administrated AFB1 on the histomorphological changes of developing cerebellar cortex and determine some AgNOR parameters of Purkinje cells of chickens during posthatching period.

MATERIALS AND METHODS

Preparations of AFB1 solutions

The test solutions were prepared according to Sur and Celik [27]. Briefly, pure AFB1 obtained from Makor Chemical Co. (Jerusalem, Israel) was diluted in benzene to prepare a stock solution containing 20 ppm AFB1 . This solution was then transferred into the vials containing the desired concentrations of AFB1 for each dose group and left overnight for the benzene to evaporate. The AFB1 residue was dissolved in absolute ethanol (99.9%), which was then reduced to 30% with sterile bi-distilled water. AFB1 concentration of these solutions was measured in duplicate by a Thin Layer Chromatography (TLC) densitometer equipped with a fluorescence detector (Perkin Elmer MPF 43A) at 365 nm excitation and 425 nm emission wave lengths, and by an ultraviolet-visible recording spectrophotometer (UV 2100; Shidmadzu, Nakagyo/KU, Kyoto, Japan) using standards.

Animals and embryonic exposure to AFB1

For the experiment, 730 fertile eggs of laying hens (BowansWhite) were used. The eggs were fumigated with 80 g potassium permanganate in 130 ml 40% formaldehyde solution/m3 for 20 minutes. The eggs were divided into 7 groups, as follows: non-treated controls (control 1, 95 eggs), drilled-sealed group (control 2, 93 eggs), solvent 30% ethanol-injected group (control 3, 96 eggs), injected with 2.5 ng AFB1 /egg (assay 1, 101 eggs), 7.5 ng AFB1 /egg (assay 2, 114 eggs), 12.5 ng AFB1 /egg (assay 3, 115 eggs) or with 17.5 ng AFB1 /egg (assay 4, 116 eggs). In the drilledsealed group, the egg shells were drilled and immediately sealed with melted paraffin in a sterile cabinet.

Treatments were performed just prior to placing the eggs into the incubator. After drilling the shell at the blunt ends of the eggs, 20 μl of test solution was injected into the air space [28] using micropipettes (Sealpette, Jencons, Finland) with sterile tips. After the injections, the holes were immediately sealed with melted paraffin. The eggs were placed in an incubator (Veyisoglu, Turkey) maintained at 37.8° C, 65% relative humidity (RH) and turned every 2 hours.

The chicks were housed in heated batteries under fluorescent lighting and consumed diets and water ad libitum. The possible mycotoxin contamination of the basal diet was determined before feeding by the method of Howel and Taylor [29] and it was found no detectable aflatoxin levels in diets (detection limit: 1 μg AF/kg food with 95% of recovery by the extraction method) [29]. Measurements were performed by TLC-densitometer (Perkin Elmer MPF 43-A). The hatched chicks received human care according to criteria outlined in the “Guide for the Care and Use of Experimental Animals” prepared by the National Academy of Sciences and published by the National Institutes of Health.

Histological investigations

Tissue samples were taken from six animals of each control and experimental group on the hatching day and 10th, 20th and 28th days after hatching. The samples, which were fixed in 4% neutral-buffered formalin, were dehydrated, cleared, and embedded in paraffin. The sections taken from the paraffin blocks were stained with haematoxylin-eosin [30] and AgNOR [31] staining methods.

AgNOR staining

The staining solution was prepared by mixing one volume of 2% gelatin in 1% aqueous formic acid and two volumes of 50% silver nitrate. The sections were stained at 37° C in the dark for 20-30 min to reach the optimal results. At the end of this period, the sections were 3 times rinsed with distilled water, dehydrated through graded ethanol to xylene and covered with entellan (Merck).

Evaluation of specimens

All specimens were examined light microscope (Leica DM2500 model with DFC-320 camera attachment giving digital images). Morphometric analyses of cerebellar cortex including thickness of molecular and granular cell layer at summit and in the fissure of folium were measured from five different areas of the sections from each animal.

To determine AgNOR parameters, 25 Purkinje cells with clearly visible nucleoli per section in five different fields from each animal were examined. The areas of the nucleus, and the areas and number of AgNORs per cell nuclei were determined. Also, the percentage of the AgNOR area relative to the whole nuclear area was calculated. All measurements were performed with IM-50 image analysis programme.

Statistical analysis

The parameters were analyzed by one-way analysis of variance and followed by post hoc Duncan multiple comparisons test using the Statistical Package for Social Sciences (SPSS version 10.0; SPSS Inc. Corp., USA). Results were considered at significant at p<0.05.

RESULTS

General histologic structure and histomorhology

The cerebella cortex completed its development in all animals of all groups. It was divided into three layers. The outmost molecular cell layer was composed of small neurons and glia cells. Granular cell layer adjacent to medulla was made of small, tightly packed neurons characterized by their great number of dark nucleus and small amount of cytoplasm. The middle layer, the Purkinje cells layer, formed the border between the molecular and granular layers. The mean thickness of molecular and granular layer at summit and fissure are shown in (Figure 1). The molecular layer was thicker in the fissure than at the summit of folium and thickness of granular layer was thicker at the summit than in the fissure of folium. Also the mean thickness of the molecular and granular layers increased through the entire experimental period. However there was not any significant difference in morphological development and the measured parameters of the cerebellar cortex among the groups. AgNOR parameters of the purkinje cells AgNORs were observed as black dots having eccentric locations in cell nuclei (Figure 2). The number of the AgNORs per Purkinje cell nuclei 1 or 3. The mean area of the Purkinje cell nucleus and the AgNOR area increased through the entire experimental period. However there were no differences in the mean area of the Purkinje cell nucleus, AgNOR area, the mean ratio of AgNOR area to Purkinje cell nucleus area and AgNOR counts among the groups (Figure 3).

DISCUSSION

AFB1 is able to cross the maternal placental barrier to reach the fetus and offers a potential threat to animal and human health in view of their teratogenicity [10,11]. The teratogenic, embryotoxic effects and developmental toxicity of AFB1 have been reported in some species [5,7-12]. In poultry, the AFB1 carry over from food to the fertilized egg leads to serious economic loss by decreasing embryo viability and hatchability [32] and by causing organ malformations [33]. Previous studies in our laboratory demonstrated that the administration of AFB1 in ovo at the beginning of early embryonic development induced immune depression [2,27,32,34], and muscle and skeletal malformations [35-37] in developing chick embryos.

Jelinek et al., [38] determined the embrytoxicity limits for AFB1 as 0.3 to 30 ng/egg and teratogenicity limits as 3 to 30 ng/ egg using the Chicken Embryotoxicity Screening Test-I (CHEST-I). Furthermore, at these doses, they observed 33% embryonic mortality, 12% heart abnormalities and 4% non-closure of the body wall at embryotoxic and teratogenic concentrations [38]. In the present study, AFB1 administration in ovo at the beginning of early embryonic development was performed with doses of 2.5, 7.5, 12.5 and 17.5 ng/egg. Our previous studies [2,37] showed that the high doses of AFB1 caused embryonic death and /or decreased hatching performance. Also, if we had administrated excessively high doses, our results would have not reflected the field situations. Besides, we know the legal upper limit in our country. When this knowledge was taken into account, we preferred the low doses of AFB1 to evaluate the effects of AFB1 on the post-hatching development of the cerebellum. Consequently, we thought that the doses of AFB1 using in this study were more reasonable for us.

The behavioral teratogenic effects of AFB1 have been also studied in rat offspring of dams injected with a subteratogenic dose of AFB1 during mid or late organogenesis and it was suggested that prenatal exposure to AFB1 produced a delay of early response development, impaired locomotor coordination, and impaired learning ability in the rat offsprings [4]. The cerebellum regulates of equilibrium of the body by making coordination of somatic motor activity and by regulating the muscle tone [39]. In addition, it is involved in some non-motor cognitive functions such as sensory discrimination, attention, learning and memory [40]. In this study, the effects of in ovo administrated AFB1 on the histomorphological changes of cerebellar cortex of chickens during post-hatching period was evaluated. The mean thickness of the molecular and granular layers increased through the entire experimental period. However there was not any significant difference in morphological development and the measured parameters of the cerebellar cortex among the groups. Also there weren’t any behavioural changes to be observed with the chicks.

The mechanism of teratogenicity caused by AFB1 has not been fully elucidated. It was suggested that the toxin arrested mitosis and induced teratogenesis due to reduction in cell proliferation during early morphogenesis [10]. Russel et al., [41] reported that the occurrence of AgNORs reflect proliferative activities of the cell. However, they claimed that an increase in the size of AgNOR clusters rather than their number was the major feature. Akar and Sur [19] suggested that investigating Purkinje cells as a model by applying the AgNOR technique offers a good approach to the functional study of structures in the central nervous system. In the present study, the nuclei of Purkinje cells and the AgNOR area increased through the entire experimental period. However there were no significant differences among the groups in AgNOR parameters.

 

CONCLUSION

The administration of a low concentration of AFB1 in ovo at the beginning of early embryonic development may not profoundly affect the development of the cerebellar cortex or the damage to the cerebellum, if occurring, might get repaired during subsequent stages of development. There is a doserelated increase in the detrimental effects of AFB1 [34].Therefore further studies, utilizing various doses higher than those used in the present study, may be conducted to evaluate the possible neurotoxic effects of AFB1 on development of cerebellar cortex.

REFERENCES

1. O?uz H, Keçeci T, Birdane YO, Önder F, Kurto?lu V. Effect of clinoptilolite on serum biochemical and haematological characters of broiler chickens during aflatoxicosis. Res Vet Sci. 2000; 41: 512-517.

2. Sur E and Celik I. Effects of aflatoxin B1on the development of the bursa of Fabricius and blood lymphocyte acid phosphatase of the chicken. Br Poult Sci. 2003; 44: 558-566.

3. Leeson S, Diaz G and Summers JD. Aflatoxins. In: Leeson S, Gonzala JDG and Summers JD, editors. Poultry Metabolic Disorders and Mycotoxins. Guelph, Canada: University Books; 1995; 249-298.

4. Kihara T, Matsuo T, Sakamoto M, Yasuda Y, Yamamoto Y, Tanimura T. Effects of prenatal aflatoxin B1exposure on behaviors of rat offspring. Toxicol Sci. 2000; 53: 392-399.

5. El-Nahla SM, Imam HM, Moussa EA, Ibrahim AM, Ghanam AR. Teratogenic effects of aflatoxin in Rabbits (Oryctolaguscuniculus). J Vet Anat. 2013; 6: 67-85.

6. Al-Ghasham A, Ata HS, El-Deep S, Meki A and Shehada S. Study of Protective Effect of Date and Nigella Sativa on Aflatoxin B1 Toxicity. Int J Health Sci (Qassim). 2008; 2: 26-44.

7. Elis J and Diapolo JA. Aflatoxin B1 and malformations. Arch Pathol.1967; 83: 53-57.

8. Mayura K, Abdel-Wahhab MA, McKenzie KS, Sarr AB, Edwards JF, Naguib K et al. Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents: Potential for hidden risks. Toxicol Sci. 1998; 41: 175-182.

9. Wangikar PB, Dwivedi P, Sharma AKand Sinha N. Effect in Rats of Simultaneous Prenatal Exposure toOchratoxin A and Aflatoxin B1. II. Histopathological Features of Teratological Anomalies Induced in Fetuses. Birth Defects Res B Dev ReprodToxicol. 2004; 71: 352-358.

10. Wangikar PB, Dwivedi P, Sinha N, Sharma AK, Telang AG. Effects of aflatoxin B1 on embryo fetal development in rabbits. Food ChemToxicol. 2005; 43: 607-615.

11. Wangikar PB, Dwivedi P, Sinha N, Sharma AK, Telang AG. Teratogenic effects in rabbits of simultaneous exposure to ochratoxin A and aflatoxin B1 with special reference to microscopic effects.Toxicology. 2005; 215: 37-47.

12. Wangikar PB, Sinha N, Dwivedi P, Sharma AK. Teratogenic Effects of Ochratoxin A and Aflatoxin B1 Alone and in Combination on PostImplantation Rat Embryos in Culture. J Turkish-German Gynecol Assoc. 2007; 8: 357-364.

13. O?uz H. A review from experimental trials on detoxification of aflatoxin in poultry feed. Eurasian J Vet Sci. 2011; 27: 1-12.

14. Bintvihok A, Thiengnin S, Doi K, Kumagai S. Residues of aflatoxins in the liver, muscle and eggs of domestic fowls. J Vet Med Sci. 2002; 64: 1037-1039.

15. Dietert RR, Qureshi MA, Nanna UC, Bloom SE. Embryonic exposure to afla toxin B1: Mutagenicity and influence on development and immunity. Environ Mutagen. 1985; 7: 715-725.

16. Costa LG, Aschner M, Vitalone A, Syversen T, Soldin OF. Developmental Neuropathology of Environmental Agents. Annu Rev PharmacolToxicol. 2004; 4: 87-110.

17. Surai PF, Mezes M. Mycotoxins and immunity: theoretical consideration and practical applications. Praxis Vet. 2005; 53: 71-88.

18. Wangikar PB, Dwivedi P, Sinha N. Teratogenic Effects of Ochratoxin A in rabbits. World Rabbit Sci. 2004; 12: 159-171.

19. Akar S and Sur E. The development of chicken cerebellar cortex and the determination of AgNOR activity of the Purkinje cell nuclei. Belg J Zool. 2010; 140: 214-222.

20. Lin JC and Cepko CL. Granule Cell Raphes and Parasagittal Domains of Purkinje Cells: Complementary Patterns in the Developing Chick Cerebellum. J Neurosci. 1998; 18: 9342-9353.

21. Robert-Fortel I, Junera HR, Gearud G, Hernandez-Verdun D. Threedimensional organization of the ribosomal genes and Ag-NOR proteins during interphase and mitosis in PtK1 cells studied by confocal microscopy. Chromosoma. 1993; 102: 146-157.

22. Khanna AK, Yadav SK, Dixit VK, Kumar M. AgNOR count and subjective AgNOR pattern assessment (SAPA) score in carcinoma of the pancreatic head including periampullary tumors. J Pancreas. 2005; 6: 575-580.

23. Crocker J and Nar P. Nucleolar organizer regions in lymphomas. J Pathol. 1987; 151: 11-118.

24. Orrea SC, Tomasi VH, Schwint AE and Itoiz ME. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis. Biotech Histochem. 2001; 76: 67-73.

25. Sur E, Celik I, Oznurlu Y, Aydin MF, Sen I and Ozparlak H. Enzyme histochemistry and AgNOR numbers in the peripheral blood leukocytes of 6 month-old Kangal bred Anatolian shepherd dogs. Rev Med Vet. 2003; 154: 591-598.

26. Guler N, Uckan S, Celik I, Oznurlu YandUckan D. Expression of Fas and Fas-ligand and analysis of argyrophilicnucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis. Int J Oral Max Surg. 2005; 34: 900-906.

27. Sur E and Celik I. Effects of aflatoksin B1on the development of chicken thymus and blood lymphocyte alpha-naphthyl acetate esterase activity. VlaamsDiergenTijds. 2005; 74: 432- 439.

28. Celik I, Oguz H, Demet O, Boydak M, Donmez HH, Sur E, et al. Embryotoxicity assay of aflatoxin produced by Aspergillusparasiticus NRLL 2999. Br Poult Sci. 2000; 41: 401-409.

29. Howel MV, Taylor PW. Determination of aflatoxins, ochratoxin A and zearalenone in mixed feeds, with detection by thin layerchromatography or high performance liquid chromatography. J AssocOffic Anal Chem. 1981; 64: 1356-1363.

30. Culling CFA, Allison RT and Barr WT. Connective Tissue. In: Culling CFA and Barr WT, editors. Cellular Pathology Technique. London, UK: Butterworths; 1985; 164-179.

31. Ayd?n MF & Celik I. Yumurtaveettavuklar?n?nkaraci?erlerindegümü? lememetoduylaboyanannücleolus organizer (AgNOR) bölgelerida??l? m?n?nbelirlenmesi. Eurasian J Vet Sci. 2005; 21: 91-99.

32. Sur E, Celik I, Oznurlu Y, Aydin MF, Oguz H, Kurtoglu V, Ozayd?n T. Enzyme histochemical and serological investigationson the immune system from chickens treated in ovo with aflatoxin B1 (AFB1). Revue Med Vet. 2011; 162: 443-448.

33. Cilievici O, Ghidus ICE, Moldovan A. The toxic and teratogenic effect of aflatoxin B1on the chick embryo development. MorpholEmbryol. 1980; 25: 309-314.

34. Sur E and Celik I. Yumurtayaverilenaflatoksin B1’in tavukdala??n?nem briyonikgeli?imiüzerindekietkileri: Histolojikbulgular. Eurasian J Vet Sci. 2004; 20: 103-110.

35. Gündüz N and OznurluY. Adverse effects of aflatoxin B1 on skeletal muscle development in broiler chickens, Br Poult Sci. 2014; 55: 684- 692.

36. Oznurlu Y and Celik I. Yumurtayaverilenaflatoksin B1’in etçipiliçlerdetibianinproksimalbüyümepla??n?nembriyonikgeli?imiüzerindekietk ilerininbelirlenmesi. Eurasian J Vet Sci. 2004; 20: 99-108.

37. Oznurlu Y, Celik I, Sur E, Ozayd?n T, O?uz H, Altunba? K. Determination of the effects of aflatoxin B1 given in ovo on the proximal tibial growth plate of broiler chickens: histologic, histometric and immunohistochemical findings. Avian Pathol. 2012; 41: 469-477.

38. Jelinek R, Peterka M, Rychter Z. Chick embryotoxicity screening test130 substances tested. Indian J Exp Biol. 1985; 23: 588-595.

39. Pal B, Chowdhury S, Ghosh RK. Comparative Anatomical Study of the Cerebellum of Man and Fowl. J AnatSoc India. 2003; 52: 32-37.

40. Selim SA and Selim AO. Effect of streptozotocin-induced diabetes mellitus on the cerebellar cortex of adult male albino rats: histological and immunohistochemical study. The Egypt J Histol. 2013; 36: 103- 113.

41. Russel DL, Aliso MR, Sarraf C. Variations in the occurrence of silverstaining nucleolar organizer regions(AgNORs) in non-proliferating and proliferating tissues. J Pathol. 1991; 165: 43-5.

Received : 24 Oct 2015
Accepted : 03 Jun 2015
Published : 04 Jun 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X